npj Breast Cancer : Impact Factor & More
eISSN: 2374-4677pISSN: 2374-4677
Open AccessShare this on:
Key Metrics
CiteScore 
6.5
Eigenfactor
0.001 - 0.005
Impact Factor
5 - 10
SJR
Q1Oncology
SNIP
1.73
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on npj Breast Cancer
npj Breast Cancer Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | NATURE PORTFOLIO |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | EUR 2890 | USD 3390 | GBP 2590 |
| Publication Time | 9 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Breast Cancer Research Foundation |
| Frequency | Continuous publication |
| Publication Start Year | 2015 |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in npj Breast Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in npj Breast Cancer
Adherence to oral endocrine therapy by menopausal status: post hoc insights from a remote monitoring randomized trial.
- 28 Jan 2026
- NPJ breast cancer
Outcomes of a prospective cohort study of PREoperative therapy and supportive care in early & locally advanced breast cancers-PreSCella study.
- 28 Jan 2026
- NPJ breast cancer
Dynamic biomarkers in hormone receptor-positive/HER2-negative breast cancer trials: a new hope for precision oncology.
- 28 Jan 2026
- NPJ breast cancer
Axillary surgery in patients with sentinel node macrometastases: secondary results of the randomized INSEMA trial.
- 27 Jan 2026
- NPJ breast cancer
Co-delivery of chemokine CXCL9 and costimulatory ligand TNFSF9 by mesenchymal stem cells reprograms the immune microenvironment for triple-negative breast cancer.
- 26 Jan 2026
- NPJ breast cancer
CD52 signaling via macrophage Siglec-G represents a therapeutic target for cancer immunotherapy.
- 24 Jan 2026
- NPJ breast cancer
Adherence to oral endocrine therapy by menopausal status: post hoc insights from a remote monitoring randomized trial.
- 28 Jan 2026
- NPJ breast cancer
Outcomes of a prospective cohort study of PREoperative therapy and supportive care in early & locally advanced breast cancers-PreSCella study.
- 28 Jan 2026
- NPJ breast cancer
Dynamic biomarkers in hormone receptor-positive/HER2-negative breast cancer trials: a new hope for precision oncology.
- 28 Jan 2026
- NPJ breast cancer
Axillary surgery in patients with sentinel node macrometastases: secondary results of the randomized INSEMA trial.
- 27 Jan 2026
- NPJ breast cancer
Co-delivery of chemokine CXCL9 and costimulatory ligand TNFSF9 by mesenchymal stem cells reprograms the immune microenvironment for triple-negative breast cancer.
- 26 Jan 2026
- NPJ breast cancer
CD52 signaling via macrophage Siglec-G represents a therapeutic target for cancer immunotherapy.
- 24 Jan 2026
- NPJ breast cancer
FAQs on npj Breast Cancer
How long has npj Breast Cancer been actively publishing? 
What is the publishing frequency of npj Breast Cancer?
How many articles did npj Breast Cancer publish last year?
What is the eISSN & pISSN for npj Breast Cancer?
What is Citescore for npj Breast Cancer?
What is SNIP score for npj Breast Cancer?
What is the SJR for npj Breast Cancer?
Who is the publisher of npj Breast Cancer?
